By considering patient preferences and clinical factors, providers can make more informed decisions
Pioglitazone improves cardiovascular outcomes by slowing down or even reversing the atherosclerotic process, independent of its glucose-lowering action
Youll receive clear, detailed information about how GLP-1 medications work, the benefits you can expect, and possible side effectssuch as nausea or appetite changes
These formulations contain the same active ingredient as branded Wegovy and Ozempic but are not FDA-approved productsthey operate under the 503A compounding exemption for patients whose needs are not met by branded alternatives
BPC-157 blocks amphetamine stereotypy and rescues haloperidol-induced catalepsy BPC-157 is anti-nociceptive in an incisional-pain model but if you need it in a pinch it counteracts morphines analgesia and lithium toxicity BPC-157 corrects basically any electrolyte problem in any direction: hyperkalemia, hypermagnesemia, and honestly you should just read this litany of various electrolyte disturbances that BPC-157 handles with ease BPC-157 reverses both atropine mydriasis and drug-induced miosis in the same rats and guinea pigs